Semaglutide Regulatory Status in Canada Health Canada Approval Status (Ozempic, Wegovy, Rybelsus, Generic) Semaglutide is the active ingredient in three Novo Nordisk products authorized for sale in Canada: Ozempic (authorized 2018 for type 2 diabetes, with an expanded indication in 2024 to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes), Rybelsus (oral semaglutide tablets authorized for type 2 diabetes), and Wegovy (authorized 2021 for chronic weight management, with an expanded indication in 2024 to reduce the risk of non-fatal myocardial infarction, and a Notice of Compliance with Conditions issued in December 2025 for non-cirrhotic metabolic dysfunction-associated steatohepatitis with moderate to advanced liver fibrosis)
Yes, when used as directed and in compliance with medical guidelines, it is safe for adults
A triple-peptide combination containing BPC-157 (gastric pentadecapeptide), GHK-Cu (copper-binding tripeptide), and TB-500 (Thymosin Beta-4 fragment) in a single formulation
The two approaches answer different research questions
If the resulting injection volume is too large, you may want to start with a fresh vial and use less water
A four-ounce chicken breast has approximately 2,440 mg of lysine